MAGELLAN LONGEVITY
HomeResearchStudy library › The effect of Berberine on weight loss in order to prevent obesity
Study summary · Metabolic health, glucose & body composition

What is the effect of Berberine on weight loss and obesity prevention?

In one paragraph

Berberine HCl 500 mg, a laboratory study (Biomedicine & Pharmacotherapy 2020, PMID 32353823) — human studies confirmed gut microbe modulation (500 mg/day), beneficial impact on cholesterol absorption gene regulation (300 mg/day), and amelioration of glucose accumulation (1.0 g/day). The abstract for Berberine HCl 500 mg states no limitations.

Source: Biomedicine & Pharmacotherapy 2020, PMID 32353823 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Biomedicine & Pharmacotherapy · 2020 · PMID 32353823 · DOI 10.1016/j.biopha.2020.110137

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Berberine shows promise for obesity prevention and treatment by influencing gut bacteria, glucose, and fat metabolism.

The question

What is the effect of Berberine on weight loss and obesity prevention?

What they tested

Berberine may be effective in managing obesity and its related metabolic consequences.

How they did it

This systematic review critically overviewed experimental studies (in vitro, human, and animal) that evaluated Berberine's efficacy in obesity management and its metabolic effects.

What they found

In preclinical models, Berberine affected gut microbiota (reducing diversity at 100 mg/kg/day), inhibited α-glycosidase (200 mg/kg/day), and decreased adipocyte differentiation (150 mg/kg/day). It also inhibited hepatic gluconeogenesis and, when associated with Red Yeast Rice, decreased lipid levels in rats (40-380 mg/kg/day). Human studies confirmed gut microbe modulation (500 mg/day), beneficial impact on cholesterol absorption gene regulation (300 mg/day), and amelioration of glucose accumulation (1.0 g/day).

Berberine Dosages and Effects
Values shown: Dosage (mg/kg/day or mg/day)
Reduced gut microbe diversity (preclinical)100
Inhibited α-glycosidase (animal)200
Decreased adipocyte differentiation (preclinical)150
Modulated gut microbes (human)500
Beneficial cholesterol absorption gene regulation (human)300
Ameliorated glucose accumulation (human)1000

Various dosages of Berberine demonstrated different effects in preclinical and human studies.

What it means

Berberine demonstrates an impact on obesity treatment and prevention through various mechanisms, including effects on gut microbiota, glucose metabolism, adipocyte differentiation, and lipid levels, as supported by both preclinical and human studies.

Limitations

The abstract does not explicitly state any limitations of the systematic review itself.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“Berberine and its effect on management of obesity and the related metabolic consequences were evaluated across in vitro, animal and human studies.”— from the published abstract, Biomedicine & Pharmacotherapy 2020

The paper at a glance

TitleThe effect of Berberine on weight loss in order to prevent obesity: A systematic review
JournalBiomedicine & Pharmacotherapy
Year2020
PMID32353823 ↗
DOI10.1016/j.biopha.2020.110137 ↗
TopicMetabolic health, glucose & body composition

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Berberine HCl 500 mg (AMPK)

In randomized trials and their meta-analyses in type 2 diabetes, berberine has produced significant reductions in fasting glucose (about 0.8 mmol/L), HbA1c (about 0.6–0.9%), total and LDL cholesterol and triglycerides, and one pilot trial found 0.5 g three times daily lowered HbA1c from 9.5% to 7.5% over three months…

Berberine HCl 500 mg (AMPK)

Berberine is a naturally occurring isoquinoline (benzylisoquinoline) alkaloid found in plants such as…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the effect of Berberine on weight loss and obesity prevention? [Plain-English summary of Biomedicine & Pharmacotherapy 2020, PMID 32353823, DOI 10.1016/j.biopha.2020.110137]. Magellan Longevity. https://magellanlongevity.com/study/berberine.html
BibTeX
@misc{magellan_berberine, title = {What is the effect of Berberine on weight loss and obesity prevention?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/berberine.html}}, note = {Plain-English summary of PubMed PMID 32353823; DOI 10.1016/j.biopha.2020.110137; Biomedicine & Pharmacotherapy 2020. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/berberine.html

Related studies in the Magellan library

All 22 Magellan summaries on metabolic health, glucose & body composition →

How this summary was made. Every section above restates what the published abstract of PMID 32353823 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.